IRIS
FRANCESCHINI, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.427
EU - Europa 5.233
AS - Asia 2.542
SA - Sud America 470
AF - Africa 144
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.363
GB - Regno Unito 1.610
CN - Cina 939
RU - Federazione Russa 885
SG - Singapore 748
IE - Irlanda 639
IT - Italia 491
UA - Ucraina 411
BR - Brasile 405
SE - Svezia 345
FR - Francia 277
DE - Germania 265
VN - Vietnam 261
HK - Hong Kong 210
FI - Finlandia 157
KR - Corea 106
ZA - Sudafrica 73
IN - India 63
TR - Turchia 48
CA - Canada 42
BD - Bangladesh 31
BE - Belgio 27
ES - Italia 27
IQ - Iraq 26
PL - Polonia 25
AR - Argentina 18
NL - Olanda 18
NG - Nigeria 16
JP - Giappone 15
ID - Indonesia 14
MX - Messico 14
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
AU - Australia 11
KE - Kenya 11
CI - Costa d'Avorio 9
CL - Cile 9
AT - Austria 8
CO - Colombia 8
EC - Ecuador 8
UZ - Uzbekistan 8
MA - Marocco 7
MY - Malesia 7
PK - Pakistan 7
EG - Egitto 6
NP - Nepal 6
VE - Venezuela 6
EU - Europa 5
JO - Giordania 5
LY - Libia 5
PY - Paraguay 5
BG - Bulgaria 4
CH - Svizzera 4
DZ - Algeria 4
IR - Iran 4
KZ - Kazakistan 4
PE - Perù 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
LB - Libano 3
LV - Lettonia 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
AO - Angola 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
LK - Sri Lanka 2
LT - Lituania 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 14.831
Salva come PNG Salva come JPEG
Città #
Southend 1.511
Dallas 805
Dublin 637
Fairfield 562
Ashburn 521
Menlo Park 445
Singapore 411
Jacksonville 338
Chandler 324
Santa Clara 282
Woodbridge 258
Moscow 254
Beijing 251
Houston 215
Wilmington 214
Hong Kong 199
Seattle 196
San Jose 192
Cambridge 190
Ann Arbor 172
New York 137
Princeton 118
The Dalles 113
Siena 109
Seoul 106
Nanjing 104
Hefei 85
Los Angeles 83
Helsinki 80
Hanoi 74
Ho Chi Minh City 72
Johannesburg 65
Lauterbourg 62
Munich 52
Boardman 51
Nanchang 48
Dearborn 39
Buffalo 37
San Diego 37
San Mateo 35
São Paulo 33
Hebei 29
Izmir 28
Rome 28
Shenyang 28
Columbus 25
London 23
Orem 22
Brussels 21
Council Bluffs 21
San Francisco 21
Washington 21
Changsha 20
Jinan 20
Kunming 20
Milan 20
Shanghai 19
Toronto 19
Turku 19
Düsseldorf 18
Málaga 17
Warsaw 16
Abuja 15
Boston 15
Frankfurt am Main 15
Jiaxing 15
Rio de Janeiro 15
Tianjin 15
Redondo Beach 14
Tokyo 14
Da Nang 12
Guangzhou 12
Montreal 12
Norwalk 12
Belo Horizonte 11
Bologna 11
Brooklyn 11
Redwood City 11
Campinas 10
Chennai 10
Dhaka 10
Dong Ket 10
Haiphong 10
Abidjan 9
Bengaluru 9
Brasília 9
Chicago 9
Kraków 9
Manchester 9
Nairobi 9
Atlanta 8
Brno 8
Florence 8
Hangzhou 8
Poplar 8
Taizhou 8
Delhi 7
Jeddah 7
Tashkent 7
Venezia 7
Totale 10.371
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 346
A novel OPA1 mutation in a family with Autosomal Dominant Optic Atrophy 330
A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy. 320
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 314
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 312
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 312
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 309
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 287
Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families 277
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 270
Cavernous malformation of the optic nerve mimicking optic neuritis 265
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 259
Aspetti angiografici con verde di indocianina in alcune patologie oculari 258
Uveiti Infantili : incidenza delle varie forme e correlazione con le malattie sistemiche 248
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 245
Molecular genetic study of Leber’s hereditary optic neurophaty (LHON): mutation screening by sequencing of ND1, ND4, ND%, ND6 genes 241
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 238
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 237
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 231
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 230
Optic perineuritis: A further cause of visual loss and disc edema in children 228
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption 228
A new Krit1 gene mutation in a family with cerebral cavernous malformation (CCM) associated with intraorbital optic nerve and cutaneous cavernous angiomas 223
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 222
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 217
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 217
Citologia congiuntivale dei portatori di lenti a contatto morbide 210
IL-6 blockade in the management of non-infectious uveitis 206
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telythromicin consumption 204
Aspetti angiografici con verde di indocianina di alcune patologie oculari 201
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 199
Atrofie ottiche " asintomatiche" della prima infanzia: difficoltà interpretative 198
Descrizione di una nuova mutazione del gene Krit1 in una forma familiare di angioma cavernoso cerebrale associata ad angioma ottico e ad angioma cutaneo 190
Subcortical low-intensity and restricted diffusion after first seizure in a child 190
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 189
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 186
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 186
Pseudoistoplasmosi oculare da Candida: descrizione di un caso clinico 185
Vasculopatia occlusiva retinica in paziente con emoglobina SC 181
Uveiti prevalentemente posteriori ed entità cliniche di incerta definizione 179
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 174
Esoftalmo da flogosi 173
Irido-corneal-endothelial syndrome: a confocal and anterior segment coherent tomography differential diagnosis 170
Serum amyloid-A in Behçet's disease 167
null 165
Influenza della flogosi oculare sulla concentrazione della sisomicina nell'umore acqueo di coniglio 164
Anakinra treatment in drug-resistant Behcet's disease: a case series. 162
Patologie dell'uvea 161
Indicazioni e valutazione degli esami infettivologicici 158
Esame con PCR sul vitreo per la diagnosi di retinite da CMV 156
Indagini semeiologiche nelle uveiti infantili 156
Heidelberg retina tomograph in the follow-up of papilledema 155
Successful use of canakinumab in a patient with resistant Behçet's disease 154
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 147
Significato del dosaggio del Retinolo e del Beta- Carotene in alcuni quadri di patologia oculare 146
Otticopatia ischemica anteriore (O.I.A.) e lesioni ischemiche cerebrali 146
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 146
Patologie della sclera 145
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 145
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. 144
null 133
null 131
Enhanced expression and function of the P2X7 purinergic receptor in peripheral blood mononuclear cells from patients with Behcet's disease 129
Human Herpesvirus 6B active infection associated with recurrent bilteral optic neuritis 122
The pain in optic neuritis: A manifestation of visceralis hyperalgesia [Il dolore nelle neuriti ottiche: una manifestazione di iperalgesia viscerale] 122
null 122
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 121
null 120
null 115
null 113
null 107
Il dolore nelle cheratopatie e nelle lesioni dell’epitelio corneale 105
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease 105
Update on the Medical Management of Gastrointestinal Behçet's Disease 92
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 76
Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection 68
Totale 14.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 100 71
2021/2022957 79 120 55 72 52 13 48 30 53 108 109 218
2022/20231.272 82 115 192 166 115 266 17 91 134 24 34 36
2023/20241.020 42 16 86 39 47 361 329 13 1 15 4 67
2024/20251.906 31 95 188 106 259 111 92 110 113 74 227 500
2025/20264.159 355 659 598 471 774 166 531 138 153 231 83 0
Totale 14.949